Today, the Allen Institute for Cell Science and New York Stem Cell Foundation (NYSCF) announced a pioneering collaboration to address this critical issue, combining two cutting-edge technologies to create more inclusive cellular models for studying disease.
Allen InstituteSep 4 2024 Today, the Allen Institute for Cell Science and New York Stem Cell Foundation announced a pioneering collaboration to address this critical issue, combining two cutting-edge technologies to create more inclusive cellular models for studying disease. This partnership will introduce the Allen Institute for Cell Science's structure tags into NYSCF's collection of ethnically diverse stem cell lines.
For too long, biomedical research has overlooked the rich diversity of human biology. This oversight has real-world consequences, contributing to widening health disparities despite overall advances in medicine. This collaboration is a crucial step toward more equitable and effective healthcare for all.
Notably, nine of these stem cell lines were derived from nuns, priests, and brothers participating in the Religious Orders Study/Memory and Aging Project at Rush University Medical Center through a collaboration between Rush University, NYSCF, and Mass General Brigham. This unique cohort provides valuable insights into aging and cognitive health, adding another layer of significance to the resource.
Cellular Biology Aging Neurons Parkinson's Disease Research
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progressionThe complex dynamics between liver cancer stem cells (CSCs) and immune cells within the tumor microenvironment (TME) are central to the progression of liver cancer. These interactions are critical in creating an immunosuppressive setting that significantly impacts the response to immunotherapy.
Read more »
Breakthrough discovery could boost stem-cell transplants by improving cell mobilizationA discovery by a three-member Albert Einstein College of Medicine research team may boost the effectiveness of stem-cell transplants, commonly used for patients with cancer, blood disorders, or autoimmune diseases caused by defective stem cells, which produce all the body's different blood cells.
Read more »
'Low-intensity' blood stem cell transplants for sickle cell appear safe for lung healthSo-called low-intensity blood stem cell transplants, which use milder conditioning agents than standard stem cell transplants, do not appear to damage the lungs and may help improve lung function in some patients with sickle cell disease (SCD), according to a three-year study of adults who underwent the procedure at the National Institutes of...
Read more »
Benefits of less intensive stem cell transplants for sickle cell diseaseSo-called low-intensity blood stem cell transplants, which use milder conditioning agents than standard stem cell transplants, do not appear to damage the lungs and may help improve lung function in some patients with sickle cell disease (SCD), according to a three-year study of adults who underwent the procedure at the National Institutes of...
Read more »
Cell therapy commercialization: Streamline your path to cell therapy commercializationMoving your cell therapy clinical trial beyond Phase I is an exciting time, marking a significant milestone. There are many therapeutic developers working to address critical patient needs in oncology, auto-immune, regenerative medicine, and other spaces.
Read more »
Human stem cell models point to glia as key players in multiple sclerosisA team of scientists from The New York Stem Cell Foundation (NYSCF) Research Institute and Case Western Reserve University has created the largest reported collection of stem cell models from multiple sclerosis (MS) patients and used them to identify unique ways in which glia—integral support cells in the brain—contribute to the disease.
Read more »